Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1741 to 1755 of 9059 results

  1. Arthrosamid for symptomatic treatment of knee osteoarthritis

    Topic prioritisation

  2. Lumella Pre-Eclampsia Test (MT687)

    Topic prioritisation

  3. OCU400 for treating retinitis pigmentosa in people 5 years and over [PDID6687]

    Awaiting development Reference number: GID-TA11905 Expected publication date: TBC

  4. SEEG-guided radiofrequency thermocoagulation in refractory epilepsy

    Topic prioritisation

  5. Ciclosporin (Vevizye) eye drops for treating moderate to severe keratoconjunctivitis [TSID12293]

    Topic prioritisation

  6. Menotrophin prefilled pen for treating anovulation or during controlled ovarian hyperstimulation [TSID12290]

    Topic prioritisation

  7. Thermal Probe Ablation for abdominal wall endometriosis

    Topic prioritisation

  8. Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids

    Topic prioritisation

  9. Epicranial focal cortex stimulation for drug-resistant focal epilepsy

    Topic prioritisation

  10. Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]

    In development Reference number: GID-TA11036 Expected publication date: TBC

  11. Etrolizumab for treating moderately to severely active ulcerative colitis [ID3827]

    Awaiting development Reference number: GID-TA10717 Expected publication date: TBC

  12. Botulinum injection of abdominal wall prior to massive incisional hernia repair

    Topic prioritisation

  13. Sebetralstat for treating acute attacks of hereditary angioedema in people aged 12 and over [ID6284]

    In development Reference number: GID-TA11334 Expected publication date: TBC

  14. Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies

    Awaiting development Reference number: GID-HTG10177 Expected publication date: TBC

  15. Inolimomab (Leukotac) for acute Graft versus host disease (aGvHD) after Allo-HSCT [ID3923]

    Awaiting development Reference number: GID-TA10823 Expected publication date: TBC